Spontaneous reporting of adverse drug reactions

QJM

Volumn 59, Issue 3, 1986, Pages 531-534

  Rawlins, Michael D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; APRINDINE; BENOXAPROFEN; BIGUANIDE DERIVATIVE; BISMUTH GALLATE; CLOZAPINE; COTRIMOXAZOLE; DIGOXIN; EMEPRONIUM BROMIDE; ESTROGEN; FANSIDAR; GESTAGEN; GLAFENINE; HALOPERIDOL; IBUPROFEN; KETOCONAZOLE; METFORMIN; METOCLOPRAMIDE; MIANSERIN; MORPHINE; NEUROLEPTIC AGENT; NITROFURANTOIN; NOMIFENSINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; OXYPHENBUTAZONE; PHENFORMIN; PHENYLBUTAZONE; PHENYLPROPANOLAMINE; PROCHLORPERAZINE; PYRIMETHAMINE; SULFADOXINE; SULFAMETHOXAZOLE; TIENILIC ACID; TRIMETHOPRIM; ZIMELDINE; ZOMEPIRAC;

ADVERSE DRUG REACTION; DRUG MONITORING; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; THERAPY;

DRUG THERAPY; GREAT BRITAIN; HUMAN;

EID: 0022547609     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/oxfordjournals.qjmed.a067980     Document Type: Editorial

References (30)

1. Inman WHW (ed.). Monitoring for Drug Safety. Lancaster: MTP Press, 1980.
2. Inman WHW. The United Kingdom. In: Inman WHW, ed. Monitoring for Drug Safety Lancaster: MTP Press, 1980: 9-48.
3. Joint Formulary Committee. British National Formulary No. 10. London: British Medical Association and the Pharmaceutical Society, 1985: 25-26.
4. Inman WHW. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J 1977: 1: 1500-1503.
5. CSM Update: Non-steroidal anti-inflammatory drugs and serious gastrointestinal reactions. Br Med J 1986; 2: (in press).
6. Meyboom RHB. Anafylaxic na het bebruik van glafinine. Ned T Geneesk 1976; 120: 926.
7. 7.van Leenwen R, Meyboom RHB. Agranulocytosis and aprindine. Lancet 1976; 2: 1137.
8. Anon. Ticrynafen recalled. FDA Drug Bull 1980; 10: 3.
9. Anon. FDA’s Zomax ADR reports. Scrip 1983; 776: 13.
10. Idanpaan-Heikkila J, et al. Agranulocytosis during treatment with clozapine. Eur J Clin Pharmacol 1977; 10: 1-5.
11. Committee on Safety of Medicines. Fansidar. Current Problems 1985; No. 15.
12. Committee on Safety of Medicines. Amiodarone (Cordarone X). Current Problems 1982; No. 8.
13. Committee on Safety of Medicines. Zimeldine (Zelmid). Current Problems 1982; No. 11.
14. Committee on Safety of Medicines. Mianserin (Bolvidon, Norvat) and arthropathy. Current Problems 1982; No. 8.
15. Committee on Safety of Medicines. Emipromium bromide and oesophageal ulceration. Current Problems 1978; No. 3.
16. Anon. Lilly suspends benoxaprofen worldwide. Scrip 1982; 717: 1.
17. Sovijani ARA, Lemola M, Stenius B, Idanpaan-Heikkila J. Nitrofurantoin-induced acute, subacute and chronic pulmonary reactions. Scand J Resp Dis 1977; 58: 41-48.
18. Holmberg L, Boman G, Böttiger LE, et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980; 69: 733-740.
19. Penn RG, Griffin JP. Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland. Br Med J 1982; 284: 1440-1442.
20. Lowe DJ. Adverse effects of bismuth subgallate. A further report from the Australian Drug Evaluation Committee. Med J Aust 2: 664-666.
21. Norvenius G, Widerlow E, Lonnerholm G. Phenylpropanolamine and mental disturbances. Lancet 1979; 2: 1367.
22. Committee on Safety of Medicines. Ketoconazole (Nizoral). Current Problems 1983; No. 10.
23. Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. Br Med J 1985; 291: 930-932.
24. Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom. Q J Med 1986; 59: 549-556.
25. Inman WHW, Vessey MP, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. Br Med J 1970; 2: 203-206.
26. Committee on Safety of Medicines. Dangers of newer antidepressants. Current Problems 1985; No. 15.
27. Committee on Safety of Medicines. Deaths associated with co-trimoxazole, ampicillin and trimethoprim. Current Problems 1985; No. 15.
28. Bergman U, Boman G, Wiholm B-E. Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 1978; 2: 464-466.
29. Committee on Safety of Medicines. CSM Update: Non-steroidal anti-inflammatory drugs and serious gastrointestinal reactions - 1. Br Med J 1986 (in press).
30. Speirs CJ, Griffin JP, Weber JCP, Glen-Bott M, Twomey C. Demography of the UK adverse reactions register. Health Trends 1984; 16: 49-52.